Literature DB >> 20567761

New insights into protein O-mannosylation in actinomycetes.

Clara Espitia1, Luis Servín-González, Raúl Mancilla.   

Abstract

Glycosylation is a common post-translational modification of surface exposed proteins and lipids present in all kingdoms of life. Information derived from bacterial genome sequencing, together with proteomic and genomic analysis has allowed the identification of the enzymatic glycosylation machinery. Among prokaryotes, O-mannosylation of proteins has been found in the actinomycetes and resembles protein O-mannosylation in fungi and higher eukaryotes. In this review we summarize the main features of the biosynthetic pathway of O-mannosylation in prokaryotes with special emphasis on the actinomycetes, as well as the biological role of the glycosylated target proteins.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20567761     DOI: 10.1039/b916394h

Source DB:  PubMed          Journal:  Mol Biosyst        ISSN: 1742-2051


  13 in total

1.  Theoretical and experimental characterization of the scope of protein O-glycosylation in Bacteroides fragilis.

Authors:  C Mark Fletcher; Michael J Coyne; Laurie E Comstock
Journal:  J Biol Chem       Date:  2010-11-29       Impact factor: 5.157

2.  Bacterial protein-O-mannosylating enzyme is crucial for virulence of Mycobacterium tuberculosis.

Authors:  Chia-Fang Liu; Laure Tonini; Wladimir Malaga; Mathilde Beau; Alexandre Stella; David Bouyssié; Mary C Jackson; Jérôme Nigou; Germain Puzo; Christophe Guilhot; Odile Burlet-Schiltz; Michel Rivière
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-02       Impact factor: 11.205

3.  Phylum-wide general protein O-glycosylation system of the Bacteroidetes.

Authors:  Michael J Coyne; C Mark Fletcher; Maria Chatzidaki-Livanis; Gerald Posch; Christina Schaffer; Laurie E Comstock
Journal:  Mol Microbiol       Date:  2013-04-17       Impact factor: 3.501

4.  Lipoprotein LprI of Mycobacterium tuberculosis Acts as a Lysozyme Inhibitor.

Authors:  Deepti Sethi; Sahil Mahajan; Chaahat Singh; Amrita Lama; Mangesh Dattu Hade; Pawan Gupta; Kanak L Dikshit
Journal:  J Biol Chem       Date:  2015-11-20       Impact factor: 5.157

5.  Similarities and differences in the glycosylation mechanisms in prokaryotes and eukaryotes.

Authors:  Anne Dell; Alaa Galadari; Federico Sastre; Paul Hitchen
Journal:  Int J Microbiol       Date:  2011-01-27

6.  The O-mannosylation and production of recombinant APA (45/47 KDa) protein from Mycobacterium tuberculosis in Streptomyces lividans is affected by culture conditions in shake flasks.

Authors:  Ramsés A Gamboa-Suasnavart; Norma A Valdez-Cruz; Laura E Cordova-Dávalos; José A Martínez-Sotelo; Luis Servín-González; Clara Espitia; Mauricio A Trujillo-Roldán
Journal:  Microb Cell Fact       Date:  2011-12-20       Impact factor: 5.328

Review 7.  Toward Understanding the Essence of Post-Translational Modifications for the Mycobacterium tuberculosis Immunoproteome.

Authors:  Cécile A C M van Els; Véronique Corbière; Kaat Smits; Jacqueline A M van Gaans-van den Brink; Martien C M Poelen; Francoise Mascart; Hugo D Meiring; Camille Locht
Journal:  Front Immunol       Date:  2014-08-11       Impact factor: 7.561

8.  Proteomic Analysis of the Secretome of Cellulomonas fimi ATCC 484 and Cellulomonas flavigena ATCC 482.

Authors:  Warren W Wakarchuk; Denis Brochu; Simon Foote; Anna Robotham; Hirak Saxena; Tamara Erak; John Kelly
Journal:  PLoS One       Date:  2016-03-07       Impact factor: 3.240

9.  Streptomyces coelicolor strains lacking polyprenol phosphate mannose synthase and protein O-mannosyl transferase are hyper-susceptible to multiple antibiotics.

Authors:  Robert Howlett; Nicholas Read; Anpu Varghese; Charles Kershaw; Y Hancock; Margaret C M Smith
Journal:  Microbiology       Date:  2018-02-01       Impact factor: 2.777

10.  O-linked glycosylation sites profiling in Mycobacterium tuberculosis culture filtrate proteins.

Authors:  Geoffrey T Smith; Michael J Sweredoski; Sonja Hess
Journal:  J Proteomics       Date:  2013-05-20       Impact factor: 4.044

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.